SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2512)1/9/2001 8:28:17 AM
From: IRWIN JAMES FRANKEL  Respond to of 52153
 
It may not be safe to come out yet. But fools rush in where angels fear to tread.

Yesterday I bought CORR, CALP, MEDX and INCY.

Unfortunately, I have a history of buying early. Hope I did not do it again.

<g>

ij



To: Biomaven who wrote (2512)1/9/2001 3:22:53 PM
From: tom pope  Read Replies (1) | Respond to of 52153
 
Does this make it safe to come out? From Briefing:

14:20 ET Genomics Stocks Upgraded : A.G. Edwards upgrading INCY and HGSI to ACCUMULATE from MAINTAIN; firm lifts MLNM to MAINTAIN from REDUCE



To: Biomaven who wrote (2512)1/11/2001 2:30:07 PM
From: Scott H. Davis  Read Replies (1) | Respond to of 52153
 
(Re: Athersys) Sounds like it would be a good time to be a specialist in intelectual property rights for pharms, as this has multicase & appeals potential. Wonder how much of their planned IPO will go towards litigation?

Sounds interesting in several regards. Scott


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News